Tandem Diabetes Care (TNDM) Exchange Rate Effect (2019 - 2026)
Tandem Diabetes Care (TNDM) posted Exchange Rate Effect of -$1.1 million for Q1 2026, down 184.72% on a QoQ basis from $1.3 million in Q4 2025, and up 42.77% year-over-year from -$753681.1 in Q1 2025.
Tandem Diabetes Care (TNDM) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Tandem Diabetes Care's Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- Quarterly Exchange Rate Effect rose 42.77% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1301.99% YoY) and the FY2025 annual result came in at $1.6 million, up 28.34% from the prior year.
- Exchange Rate Effect was -$1.1 million for Q1 2026 at Tandem Diabetes Care, down from $1.3 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.2 million in Q4 2024 and bottomed at -$1.9 million in Q1 2025.
- A 5-year average of $141588.2 and a median of $3000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 3200.0% — and 2023, when it soared 14600.0%.
- Tandem Diabetes Care's Exchange Rate Effect stood at $1.0 million in 2022, then slumped by 57.45% to $440000.0 in 2023, then surged by 392.27% to $2.2 million in 2024, then plunged by 41.37% to $1.3 million in 2025, then sank by 184.72% to -$1.1 million in 2026.
- Business Quant data shows TNDM's Exchange Rate Effect at -$1.1 million in Q1 2026, $1.3 million in Q4 2025, and $605000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 Mn |
| Mar 31, 2026 | -1.08 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 605,000.00 |
| Sep 30, 2025 | 605,000.00 |
| Jun 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | -1.02 Mn |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | 535,000.00 |
| Jun 30, 2024 | 535,000.00 |
| Mar 31, 2024 | -423,000.00 |
| Mar 31, 2024 | -423,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Dec 31, 2023 | 440,000.00 |